MDK and neuroblastoma: MDK has been found to be over-expressed in various human cancers, including esophageal, gastric, colon, pancreatic, hepatocellular, lung, breast, and urinary bladder carcinomas, as well as neuroblastomas and Wilms' tumors [11,12].